Artigos com autorizações de acesso público - Jane MezaSaiba mais
4 artigos não disponíveis publicamente
Caregiving demand and difficulty in older adult spousal caregivers after coronary artery bypass surgery
EO Park, BC Yates, KL Schumacher, J Meza, K Kosloski, C Pullen
Geriatric Nursing 34 (5), 383-387, 2013
Autorizações: US National Institutes of Health
An assessment of factors associated with neurocognitive decline in people living with HIV
Z Naveed, HS Fox, CS Wichman, P May, CM Arcari, J Meza, L Baccaglini
International journal of STD & AIDS 33 (1), 38-47, 2022
Autorizações: US National Institutes of Health
Weekly vinorelbine and paclitaxel in older patients with advanced non-small cell lung cancer: A phase II Fred and Pamela Buffet Cancer Center Clinical Trials Network study
MM Huerter, JL Meza, MS Copur, A Tolentino, AS Marr, M Ketcham, ...
Journal of geriatric oncology 8 (1), 18-22, 2017
Autorizações: US National Institutes of Health
Intervention fidelity in a translational study: lessons learned.
BC Yates, KL Schumacher, JF Norman, KS Krogstrand, J Meza, ...
Research & Theory for Nursing Practice 27 (2), 2013
Autorizações: US National Institutes of Health
70 artigos disponíveis publicamente
Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia: a report from the children's oncology group
S Bhatia, W Landier, M Shangguan, L Hageman, AN Schaible, AR Carter, ...
Journal of Clinical Oncology 30 (17), 2094-2101, 2012
Autorizações: US National Institutes of Health
CD4+ regulatory and effector/memory T cell subsets profile motor dysfunction in Parkinson’s disease
JAH Saunders, KA Estes, LM Kosloski, HE Allen, KM Dempsey, ...
Journal of Neuroimmune Pharmacology 7, 927-938, 2012
Autorizações: US National Institutes of Health
Randomized clinical trial of therapeutic music video intervention for resilience outcomes in adolescents/young adults undergoing hematopoietic stem cell transplant: a report …
SL Robb, DS Burns, KA Stegenga, PR Haut, PO Monahan, J Meza, ...
Cancer 120 (6), 909-917, 2014
Autorizações: US National Institutes of Health
Results of the Intergroup Rhabdomyosarcoma Study Group D9602 protocol, using vincristine and dactinomycin with or without cyclophosphamide and radiation therapy, for newly …
R Beverly Raney, DO Walterhouse, JL Meza, RJ Andrassy, JC Breneman, ...
Journal of Clinical Oncology 29 (10), 1312-1318, 2011
Autorizações: US National Institutes of Health
MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells
P Chaturvedi, AP Singh, S Chakraborty, SC Chauhan, S Bafna, JL Meza, ...
Cancer research 68 (7), 2065-2070, 2008
Autorizações: US National Institutes of Health
Neuromagnetic evidence of abnormal movement-related beta desynchronization in Parkinson's disease
E Heinrichs-Graham, TW Wilson, PM Santamaria, SK Heithoff, ...
Cerebral cortex 24 (10), 2669-2678, 2014
Autorizações: US National Institutes of Health
Shorter-duration therapy using vincristine, dactinomycin, and lower-dose cyclophosphamide with or without radiotherapy for patients with newly diagnosed low-risk …
DO Walterhouse, AS Pappo, JL Meza, JC Breneman, AA Hayes-Jordan, ...
Journal of Clinical Oncology 32 (31), 3547-3552, 2014
Autorizações: US National Institutes of Health
The molecular etiology of breast cancer: evidence from biomarkers of risk
NW Gaikwad, L Yang, P Muti, JL Meza, S Pruthi, JN Ingle, EG Rogan, ...
International journal of cancer 122 (9), 1949-1957, 2008
Autorizações: US National Institutes of Health
Weight patterns in children with higher risk ALL: a report from the Children's Oncology Group (COG) for CCG 1961
JS Withycombe, JE Post‐White, JL Meza, RG Hawks, LM Smith, N Sacks, ...
Pediatric blood & cancer 53 (7), 1249-1254, 2009
Autorizações: US National Institutes of Health
Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson’s disease trial
HE Gendelman, Y Zhang, P Santamaria, KE Olson, CR Schutt, D Bhatti, ...
NPJ Parkinson's disease 3 (1), 10, 2017
Autorizações: US Department of Defense, US National Institutes of Health
Long-acting parenteral nanoformulated antiretroviral therapy: interest and attitudes of HIV-infected patients
J Williams, HR Sayles, JL Meza, P Sayre, U Sandkovsky, HE Gendelman, ...
Nanomedicine 8 (11), 1807-1813, 2013
Autorizações: US National Institutes of Health
A year-long extended release nanoformulated cabotegravir prodrug
TA Kulkarni, AN Bade, B Sillman, BLD Shetty, MS Wojtkiewicz, N Gautam, ...
Nature materials 19 (8), 910-920, 2020
Autorizações: US National Institutes of Health
Local control and outcome in children with localized vaginal rhabdomyosarcoma: a report from the Soft Tissue Sarcoma committee of the Children's Oncology Group
DO Walterhouse, JL Meza, JC Breneman, SS Donaldson, ...
Pediatric blood & cancer 57 (1), 76-83, 2011
Autorizações: US National Institutes of Health
Group-wide, prospective study of ototoxicity assessment in children receiving cisplatin chemotherapy (ACCL05C1): a report from the Children’s Oncology Group
KR Knight, L Chen, D Freyer, R Aplenc, M Bancroft, B Bliss, H Dang, ...
Journal of clinical oncology 35 (4), 440-445, 2017
Autorizações: US National Institutes of Health
Local control with reduced-dose radiotherapy for low-risk rhabdomyosarcoma: a report from the Children’s Oncology Group D9602 study
J Breneman, J Meza, SS Donaldson, RB Raney, S Wolden, J Michalski, ...
International Journal of Radiation Oncology* Biology* Physics 83 (2), 720-726, 2012
Autorizações: US National Institutes of Health
Weight change during childhood acute lymphoblastic leukemia induction therapy predicts obesity: a report from the Children's Oncology Group
JS Withycombe, LM Smith, JL Meza, C Merkle, MS Faulkner, L Ritter, ...
Pediatric blood & cancer 62 (3), 434-439, 2015
Autorizações: US National Institutes of Health
As informações de publicação e financiamento são determinadas automaticamente por um programa de computador